FidoCure™
Precision Medicine for Canine Cancer
• DNA sequencing diagnostic in a CLIA certified lab
• Telemedicine-enabled clinical guidance
• Access to targeted therapy, FDA approved for humans
• Administered orally at your clinic or the patient’s home
• Complies with USP 800
Differentiate your practice with advanced, personalized canine cancer care.
The options to treat canine cancer are often limited, while pet parents are increasingly willing to do more for their dogs. FidoCure™ enables veterinarians to differentiate their practice with advanced, personalized canine cancer care, previously only available for humans.
Human Oncology
1.6M New Annual Cases
84+ Targeted Therapies in use
Veterinary Oncology
6M New Annual Cases
1 Targeted Therapy
All Cancers are Eligible for FidoCure™
• Genomic diagnostic test to uncover possible tumor-associated changes
• Access to targeted therapeutics as a treatment option
• Oral therapy is easy to administer at home
• An alternative to DNA-damaging chemotherapy or radiation
• All our therapeutic suggestions are for FDA approved human drugs
• Many mast cell tumors are c-Kit driven
• Access to a c-Kit targeted therapy as another option for drug-refractory cancers
• An alternative to DNA-damaging chemotherapy or radiation
• Oral therapy is easy to administer at home
• FDA approved human drug
• Many transitional cell carcinomas are BRAF+
• Access to a EGFR/HER2 and/or MEK targeted therapy suited to treatment of TCC
• An alternative to DNA-damaging chemotherapy or radiation
• Oral therapy is easy to administer at home
• FDA approved human drug
Why Offer FidoCure™ to Families
“ Almost every cancer in humans is treated with one or a number of different targeted therapies. We believe that that’s going to be the case for veterinary oncology in the near future.”
— Dr. Gerald Post · DVM MEM DACVIM
Chief Veterinary Officer, One Health Company
Hundreds of dogs have benefitted from FidoCure™ this year.
Dr. Aarti Sabhlok
DVM, DACVIM
“It narrows it down a little bit and gives me additional options and sometimes they’re drugs I wouldn’t have thought to use for that particular patient or that particular cancer.”
Dr. Brooke Fowler
DVM MS DACVIM
“FidoCure™ is advancing the field of veterinarian oncology by providing the technology to help vet oncologists pinpoint the genetic mutation that may be causing a dog's cancer and providing treatment alternatives that use the latest advances in human oncology.”
Dr. Rob Proietto
VMD, MS
“All of our cases have done tremendous so far so I am hopeful for a long quality of life ahead”